Truist raised the firm’s price target on UiPath (PATH) to $17 from $12 and keeps a Hold rating on the shares following “solid” Q3 results that beat the firm’s estimates across the top and bottom line. The firm remains “a bit cautious” as it looks for both sustained execution signals and a growth inflection via agentic before becoming more constructive, but cites higher revenue estimates and an improved valuation outlook for its raised target.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH:
